24/7 Wall Street
30 Sept 2026, 19:35 UTC · 1h ago
Verdict
Headline takes no side. We score AZN +0.20 across four claims — slightly bullish.
+0.20slightly bullish
More positive than 58% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish · 1 new · 3 priced in
A 100% default tariff on imported branded drugs expanded to cover all drugmakers starting September 29, 2026.
Newbegan on September 29, 2026
More negative than 94% of claims this week
Large-cap firms including Pfizer, Eli Lilly, and J&J secured 0% tariff rates until January 2029 by agreeing to most-favored-nation pricing and US manufacturing plans.
Priced in
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
So whatThese companies traded future price concessions for a ~2.3-year window of zero duties, protecting near-term EPS.
More positive than 80% of claims this week
Companies with approved US manufacturing plans pay a 20% tariff that escalates to 100% by 2030.
Priced inschedule has been public since spring
So whatThe 80 percentage point increase over the next four years creates a mounting headwind for COGS through FY2030.
More negative than 76% of claims this week
Generics, biosimilars, orphan drugs, and cell and gene therapies are exempt from the tariffs.
Priced inschedule has been public since spring
More positive than 55% of claims this week
Which stocks this story touches
More positive than 58% of ticker scores this week
Successfully negotiated tariff exemptions through onshoring and price deals.
More positive than 58% of ticker scores this week
Successfully negotiated tariff exemptions through onshoring and price deals.
More positive than 58% of ticker scores this week
Successfully negotiated tariff exemptions through onshoring and price deals.
More positive than 58% of ticker scores this week
Successfully negotiated tariff exemptions through onshoring and price deals.
More positive than 58% of ticker scores this week
Successfully negotiated tariff exemptions through onshoring and price deals.
More positive than 58% of ticker scores this week
Successfully negotiated tariff exemptions through onshoring and price deals.
More positive than 58% of ticker scores this week
Successfully negotiated tariff exemptions through onshoring and price deals.
More positive than 58% of ticker scores this week
Successfully negotiated tariff exemptions through onshoring and price deals.
More positive than 58% of ticker scores this week
Successfully negotiated tariff exemptions through onshoring and price deals.
More positive than 58% of ticker scores this week
Successfully negotiated tariff exemptions through onshoring and price deals.
Near neutral — 91% of ticker scores this week are stronger
The company is mentioned in a headline regarding upcoming earnings but no sentiment is provided.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Reuters
1h ago
−1.7%
Price is moving against the score
$161.48 vs $164.21 close before publication (Sep 29) · not market-adjusted
AZN chart →
